SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-097791
Filing Date
2023-09-01
Accepted
2023-09-01 16:30:36
Documents
12
Period of Report
2023-08-29
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325265d1_8k.htm   iXBRL 8-K 24174
  Complete submission text file 0001104659-23-097791.txt   197427

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nviv-20230829.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20230829_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20230829_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2325265d1_8k_htm.xml XML 3332
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 231232973
SIC: 3841 Surgical & Medical Instruments & Apparatus